Published in
American Association for the Advancement of Science, Science Translational Medicine, 604(13), 2021
DOI: 10.1126/scitranslmed.aax8891
Links
Tools
PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
Journal article published in 2021 by
Areum Jo 
,
Yunjong Lee ,
Tae-In Kam ,
Sung-Ung Kang ,
Stewart Neifert ,
Senthilkumar S. Karuppagounder ,
Rin Khang ,
Hojin Kang,
Hyejin Park ,
Shih-Ching Chou,
Sungtaek Oh ,
Haisong Jiang,
Deborah A. Swing,
Sangwoo Ham ,
Sheila Pirooznia
and other authors.
,
Yunjong Lee ,
Tae-In Kam ,
Sung-Ung Kang ,
Stewart Neifert ,
Senthilkumar S. Karuppagounder ,
Rin Khang ,
Hojin Kang,
Hyejin Park ,
Shih-Ching Chou,
Sungtaek Oh ,
Haisong Jiang,
Deborah A. Swing,
Sangwoo Ham ,
Sheila Pirooznia
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Farnesol enhances the amounts of farnesylated PARIS and PGC-1α, preventing dopaminergic neuronal loss in Parkinson’s disease models.